Search details
1.
A call to action to harmonize patient-reported outcomes evidence requirements across key European HTA bodies in oncology.
Future Oncol
; 18(29): 3323-3334, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-36053168
2.
Trends in real-world biomarker testing and overall survival in US patients with advanced non-small-cell lung cancer.
Future Oncol
; 18(39): 4385-4397, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-36656547
3.
DNA damage repair gene mutation testing and genetic counseling in men with/without prostate cancer: a systematic review.
Future Oncol
; 17(7): 853-864, 2021 Mar.
Article
in English
| MEDLINE | ID: mdl-33263430
4.
Effect of DNA damage response mutations on prostate cancer prognosis: a systematic review.
Future Oncol
; 15(28): 3283-3303, 2019 Oct.
Article
in English
| MEDLINE | ID: mdl-31535940
5.
Payer perceptions on the use of patient-reported outcomes in oncology decision making.
J Manag Care Spec Pharm
; 28(2): 188-195, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34806908
6.
A systematic review of international guidelines and recommendations for the genetic screening, diagnosis, genetic counseling, and treatment of BRCA-mutated breast cancer.
Cancer Manag Res
; 11: 2321-2337, 2019.
Article
in English
| MEDLINE | ID: mdl-30962720
7.
A systematic review of the international prevalence of BRCA mutation in breast cancer.
Clin Epidemiol
; 11: 543-561, 2019.
Article
in English
| MEDLINE | ID: mdl-31372057
8.
Productivity losses associated with cardiovascular disease: a systematic review.
Expert Rev Pharmacoecon Outcomes Res
; 16(6): 759-769, 2016 Dec.
Article
in English
| MEDLINE | ID: mdl-27831848
Results
1 -
8
de 8
1
Next >
>>